Some Think GLP-1s Could Be The Next Treatments For Alzheimer’s. So Far, Drug Trial Results Are A Mixed Bag

Recent trials of two GLP-1s, semaglutide and liraglutide, reported very different results in Alzheimer’s disease patients.